Startup Valuation Under UP Policy: Treating Grants, Allowances, and Incubation Benefits

The UP Startup Policy 2020 (as amended in 2022) provides three categories of direct financial support to recognised startups: a Sustenance Allowance of ₹17,500 per month for 12 months (extendable to 18 months on special grounds); Seed Capital as marketing assistance of up to ₹7.5 Lakhs disbursed in three tranches linked to milestones; and a Prototype Grant of up to ₹5 Lakhs. Lease reimbursement as a distinct instrument for startups is not explicitly named in the current 2022 Amendment text — the reimbursement provisions in the Policy relate to incubators rather than individual startups, with free incubation space provided for up to 12 months at government-managed facilities.

The core valuation question this article addresses is methodological: when a registered valuer sits down to determine pre-money value for a UP-recognised startup that has received or will receive these benefits, should the policy subsidies be treated as recurring operating cash flows inside the DCF model, or normalised out as one-time, non-recurring grants? The answer has material consequences — the difference can be ₹30–50 Lakhs in pre-money value for an early-stage startup, which is not a rounding error.

No existing IBBI guidance or ICAI technical guide specifically addresses the treatment of state-policy subsidies in startup valuations. This article establishes a framework drawing on first principles of DCF normalisation, IVS concepts, and the specific characteristics of UP Policy instruments.

Every valuer who has worked with a state-recognised startup has hit the same wall. The founders point to the government support letter. The policy document confirms ₹17,500 per month for a year, a ₹7.5 Lakh seed grant, free incubation space worth ₹1.5 Lakhs over twelve months. The founders want it all in the revenue line. They want a DCF that treats these inflows as proof of commercial traction.

The investor sitting across the table wants none of it in the model. To them, a government allowance is not a customer. A seed grant is not a contract. And a reimbursed rent is not an operating cost structure that reflects how the business will actually run once the policy window closes.

The question is not whether UP Policy support is real money — it is. The question is whether it is the right kind of money to include in a forward-looking valuation of the business itself.

Both positions are defensible in isolation. Neither is entirely correct. The valuer’s job is to apply a methodology that is honest about what these instruments actually are, what they signal about the business, and how they should — or should not — affect the number a founder takes into a seed or Series A conversation.

The Three Instruments — and What They Are Not

Before any valuation treatment can be determined, the nature of each instrument must be understood precisely. The UP Startup Policy 2020, as amended in 2022 and administered through the StartInUP portal, provides the following to recognised startups incubated at government-approved facilities:

A critical distinction that many founders and some valuers overlook: the lease reimbursement provision in the UP Policy applies to incubators — not directly to startups. What the startup receives is free incubation space for up to 12 months, the economic equivalent of a rent subsidy. This has a notional value — typically ₹1–2 Lakhs annually depending on the incubator location — but it is a benefit-in-kind, not a cash receipt.

The combined maximum cash receipts under the standard policy for a startup not qualifying for additional incentives are: ₹2.1 Lakhs in Sustenance Allowance (₹17,500 × 12), ₹7.5 Lakhs in Seed Capital, and ₹5 Lakhs in Prototype Grant — a total of ₹14.6 Lakhs in direct cash grants. For qualifying startups in Purvanchal/Bundelkhand or with women/EWS cofounders holding over 26% equity, the Sustenance Allowance and Seed Capital each attract a 50% top-up, bringing the combined maximum to approximately ₹19.7 Lakhs.

Inside or Outside the DCF? — The Core Methodological Choice

When building a DCF model for a UP-recognised startup, the valuer faces three distinct decisions — one for each primary instrument type. Each decision must be made on the basis of what the instrument actually represents in the context of a sustainable, forward-looking business model.

Sustenance Allowance — Normalise Out

The Sustenance Allowance of ₹17,500 per month is the most straightforward case. It is a time-limited, policy-dependent cash inflow that will not recur after the 12-month window closes. No investor or acquirer of this startup’s equity will pay a multiple on a government allowance. It has no bearing on the startup’s ability to generate revenue from customers, and including it in the recurring cash flow projection produces a model that will not survive due diligence.

The correct treatment is to normalise the Sustenance Allowance out of the EBITDA used as the basis for the DCF — exactly as a valuer would normalise out a one-time legal settlement recovery, an insurance claim, or a founder’s personal expense run through the company. The allowance may be acknowledged in the notes as a source of working capital support, but it does not belong in the revenue or cash flow projection.

Worked Example: A UP-recognised startup receives ₹17,500/month from April 2025 to March 2026. In the base year P&L used for the DCF, this appears as ₹2.1 Lakhs in ‘Other Income’. If the valuer includes this in EBITDA and applies a 3x revenue multiple or a 20% discount rate DCF, it adds approximately ₹6.3–10.5 Lakhs to the indicated pre-money value — for income that will not exist in Year 2. Normalising it out removes this distortion.

Seed Capital and Prototype Grant — Treat as Cost Reduction, Not Revenue

The Seed Capital of ₹7.5 Lakhs and the Prototype Grant of ₹5 Lakhs are one-time capital infusions disbursed against specific milestones. They are not revenue. They do not recur. The correct treatment is to reflect them as a reduction in the startup’s cash funding requirement — effectively reducing the amount of equity capital the founders need to raise to reach the same milestone.

In a pre-money valuation context, this has a different but equally important effect: the grants improve the startup’s runway without diluting equity. A startup that has already received ₹12.5 Lakhs in non-dilutive government grants to reach MVP stage is a more capital-efficient business than one that has not — and that efficiency can be reflected in a lower burn rate assumption in the DCF, or in a higher quality score in a Scorecard or Risk Factor Summation approach.

Crucially, the milestone-linked tranche structure of the Seed Capital is relevant. Since 60% of the ₹7.5 Lakhs (₹4.5 Lakhs) is disbursed only on achieving milestones, a valuer should not assume the full ₹7.5 Lakhs is received unless the milestones have been documented as met. Projecting future grant receipts that are milestone-contingent without evidence of milestone achievement is a valuation error.

Free Incubation Space — Notional Adjustment Only

Free incubation space for 12 months saves the startup a real cost — typically ₹8,000 to ₹15,000 per month depending on the incubator and city. Over 12 months, this is a ₹1–1.8 Lakh saving. The treatment in the DCF is to ensure that the post-incubation operating cost structure correctly reflects the rent or co-working cost the startup will actually incur once the free period ends. This is a normalisation of the cost base, not a revenue recognition question.

A startup model that shows zero rent expense in Year 1 because of free incubation, but fails to budget for market-rate office costs from Year 2 onward, is overstating free cash flow in the outer years of the projection. This is common and consequential — particularly when terminal value is calculated as a multiple of Year 5 EBITDA, since an understated Year 5 cost base inflates the terminal value directly.

How Treatment Choices Affect Pre-Money — A Worked Illustration

Illustrative Example — TechSprout Solutions Pvt. Ltd. (Fictionalised)

UP-recognised startup | B2B SaaS | Revenue ₹24 Lakhs p.a. | Pre-seed round | All figures illustrative

The ₹66 Lakh gap between the unadjusted and normalised pre-money valuations is not a marginal difference. For a startup at the pre-seed stage, it represents the difference between a credible investor conversation and a number that will be immediately challenged in due diligence. An investor who has seen a hundred startup decks will identify an unnormalised government grant in the revenue line within minutes — and the credibility loss from that discovery is harder to recover than the valuation haircut itself.

What UP Policy Receipt Does Signal — And How to Use It

Normalising out the grants does not mean ignoring them. A startup that has successfully applied for and received UP Policy recognition, secured incubation at a government-approved facility, and met the milestones required to receive Seed Capital in multiple tranches has demonstrated something real: it has passed a structured government due diligence process.

In a Scorecard or Risk Factor Summation valuation — both of which are more appropriate than DCF for very early-stage startups with minimal revenue — UP Policy recognition is a legitimate quality signal. It reduces the execution risk score. It demonstrates that the founding team can navigate regulatory processes. It signals access to a policy ecosystem that provides runway extension without equity dilution.

The grants should be normalised out of the DCF. The fact that they were received should be presented as a risk-reducing quality attribute in every other method used alongside the DCF.

This distinction matters practically. A valuer building a pre-money opinion for a UP-recognised startup should present the DCF on a normalised basis — clean operating cash flows, post-incubation cost structure, no one-time government inflows in the revenue model. Separately, in the qualitative overlay or in a scorecard framework, the policy recognition and demonstrated ability to access non-dilutive funding should be reflected positively. These are two different statements about value. Both belong in the report. They should not be conflated.

The Valuer’s Checklist — UP-Recognised Startups

• Identify all policy receipts explicitly. Obtain the StartInUP approval letter, disbursement confirmations, and milestone completion records before building the model.
• Normalise the Sustenance Allowance out of EBITDA. Remove it from Other Income or Revenue in the base year and all projected years. It does not recur.
• Treat Seed Capital and Prototype Grant as capex offsets. Reduce the cash funding requirement by the amount received. Do not include as revenue or recurring income.
• Confirm milestone status before projecting future grant tranches. Only include Seed Capital tranches that have been received or where milestones are documentably met.
• Build post-incubation cost structure into Year 2 onwards. Include market-rate office or co-working costs from the period after free incubation ends. This prevents terminal value overstatement.
• Present policy recognition as a qualitative value attribute. In Scorecard or Risk Factor methods, explicitly score UP Policy recognition as a positive on execution risk and runway management.
• Disclose treatment in the report. State clearly in the valuation report that government subsidies have been normalised out of the DCF and why. This strengthens the report’s defensibility with investors and tax authorities.

The Default Methodology for State-Recognised Startups

The question is never whether the grants are real. They are. The question is whether they are the business. They are not.

India’s state startup policies — and UP’s in particular — are genuinely useful instruments for founders. They extend runway, fund prototype development, and reduce the amount of equity capital that needs to be raised at the most dilutive stage of the company’s life. None of that value disappears when a valuer normalises the grants out of the DCF.

What the normalisation achieves is clarity. It separates what the government has contributed from what the business itself has built. Investors are buying into the business — not into the policy ecosystem. A pre-money valuation that honestly represents the clean operating economics of a UP-recognised startup, and separately acknowledges the policy support as a quality signal, is a stronger foundation for a fundraise than an inflated number that will not survive the first investor question.

As more Indian states develop structured startup policies with quantified financial support, the methodological framework established here — normalise time-limited grants out of recurring cash flows, reflect policy recognition as a risk-reduction attribute in qualitative scoring, and correctly model post-subsidy cost structures — will become the standard approach for any valuer working in the state-supported startup ecosystem.